Growth Metrics

ClearPoint Neuro (CLPT) Gains from Investment Securities (2017 - 2026)

ClearPoint Neuro's Gains from Investment Securities history spans 14 years, with the latest figure at $195000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 132.14% to $195000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a 1245.45% increase, with the full-year FY2024 number at $1.4 million, down 6.88% from a year prior.
  • Gains from Investment Securities hit $195000.0 in Q4 2025 for ClearPoint Neuro, down from $1.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CLPT hit a ceiling of $3.3 million in Q2 2025 and a floor of $5000.0 in Q1 2023.
  • Historically, Gains from Investment Securities has averaged $715855.0 across 5 years, with a median of $151000.0 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 99.11% in 2024 and later surged 24366.28% in 2025.
  • Tracing CLPT's Gains from Investment Securities over 5 years: stood at $57000.0 in 2021, then surged by 489.47% to $336000.0 in 2022, then tumbled by 88.99% to $37000.0 in 2023, then surged by 127.03% to $84000.0 in 2024, then skyrocketed by 132.14% to $195000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CLPT at $195000.0 in Q4 2025, $1.3 million in Q3 2025, and $3.3 million in Q2 2025.